Cargando…
Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis
Objective: We assessed the efficacy of colchicine in COVID-19 patients through a systematic review. Methods: Six databases were searched until March 2022 for studies assessing colchicine versus control in hospitalized patients with COVID-19. The primary outcome was mortality, and secondary outcome w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105993/ https://www.ncbi.nlm.nih.gov/pubmed/35566737 http://dx.doi.org/10.3390/jcm11092615 |
_version_ | 1784708173706297344 |
---|---|
author | Toro-Huamanchumo, Carlos J. Benites-Meza, Jerry K. Mamani-García, Carlos S. Bustamante-Paytan, Diego Gracia-Ramos, Abraham Edgar Diaz-Vélez, Cristian Barboza, Joshuan J. |
author_facet | Toro-Huamanchumo, Carlos J. Benites-Meza, Jerry K. Mamani-García, Carlos S. Bustamante-Paytan, Diego Gracia-Ramos, Abraham Edgar Diaz-Vélez, Cristian Barboza, Joshuan J. |
author_sort | Toro-Huamanchumo, Carlos J. |
collection | PubMed |
description | Objective: We assessed the efficacy of colchicine in COVID-19 patients through a systematic review. Methods: Six databases were searched until March 2022 for studies assessing colchicine versus control in hospitalized patients with COVID-19. The primary outcome was mortality, and secondary outcome was length of hospitalization. Inverse variance and random effect meta-analyses were performed. The strength of evidence was assessed using GRADE. Results: Nine studies (five randomized clinical trials (RCTs) and four non-randomized studies of intervention (NRSI); n = 13,478). Colchicine did not reduce mortality in comparison with the standard of care in RCTs (RR 0.99; 95%CI 0.90 to 1.10; p = 0.90); however, it did reduce mortality in NRSI studies (RR 0.45; 95%CI 0.26 to 0.77; p = 0.02). In the analysis of RCTs, colchicine did not reduce the length of hospitalization in comparison with the standard of care (MD: −2.25 days; 95%CI: −9.34 to 4.84; p = 0.15). Most studies were scored as having a high risk of bias. Quality of evidence was very low for primary and secondary outcomes. Conclusion: Colchicine did not reduce the mortality and length of hospitalization in comparison with the standard of care in hospitalized patients with COVID-19. The published evidence is insufficient and of very low quality to recommend treatment in patients with COVID-19. |
format | Online Article Text |
id | pubmed-9105993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91059932022-05-14 Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis Toro-Huamanchumo, Carlos J. Benites-Meza, Jerry K. Mamani-García, Carlos S. Bustamante-Paytan, Diego Gracia-Ramos, Abraham Edgar Diaz-Vélez, Cristian Barboza, Joshuan J. J Clin Med Systematic Review Objective: We assessed the efficacy of colchicine in COVID-19 patients through a systematic review. Methods: Six databases were searched until March 2022 for studies assessing colchicine versus control in hospitalized patients with COVID-19. The primary outcome was mortality, and secondary outcome was length of hospitalization. Inverse variance and random effect meta-analyses were performed. The strength of evidence was assessed using GRADE. Results: Nine studies (five randomized clinical trials (RCTs) and four non-randomized studies of intervention (NRSI); n = 13,478). Colchicine did not reduce mortality in comparison with the standard of care in RCTs (RR 0.99; 95%CI 0.90 to 1.10; p = 0.90); however, it did reduce mortality in NRSI studies (RR 0.45; 95%CI 0.26 to 0.77; p = 0.02). In the analysis of RCTs, colchicine did not reduce the length of hospitalization in comparison with the standard of care (MD: −2.25 days; 95%CI: −9.34 to 4.84; p = 0.15). Most studies were scored as having a high risk of bias. Quality of evidence was very low for primary and secondary outcomes. Conclusion: Colchicine did not reduce the mortality and length of hospitalization in comparison with the standard of care in hospitalized patients with COVID-19. The published evidence is insufficient and of very low quality to recommend treatment in patients with COVID-19. MDPI 2022-05-06 /pmc/articles/PMC9105993/ /pubmed/35566737 http://dx.doi.org/10.3390/jcm11092615 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Toro-Huamanchumo, Carlos J. Benites-Meza, Jerry K. Mamani-García, Carlos S. Bustamante-Paytan, Diego Gracia-Ramos, Abraham Edgar Diaz-Vélez, Cristian Barboza, Joshuan J. Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis |
title | Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis |
title_full | Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis |
title_fullStr | Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis |
title_short | Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis |
title_sort | efficacy of colchicine in the treatment of covid-19 patients: a systematic review and meta-analysis |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105993/ https://www.ncbi.nlm.nih.gov/pubmed/35566737 http://dx.doi.org/10.3390/jcm11092615 |
work_keys_str_mv | AT torohuamanchumocarlosj efficacyofcolchicineinthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT benitesmezajerryk efficacyofcolchicineinthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT mamanigarciacarloss efficacyofcolchicineinthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT bustamantepaytandiego efficacyofcolchicineinthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT graciaramosabrahamedgar efficacyofcolchicineinthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT diazvelezcristian efficacyofcolchicineinthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT barbozajoshuanj efficacyofcolchicineinthetreatmentofcovid19patientsasystematicreviewandmetaanalysis |